Beximco starts exporting to Belize

1 April 2007

Bangladeshi drugmaker Beximco Pharmaceuticals, a specialist in the production of generic medications and active pharmaceutical ingredients, says that it has begun exporting drugs to Belize in Central America. The firm explained that the first shipment contained supplies of 25 different products, including antibacterials, antihypertensives, lipid lowering drugs, pain relivers, respiratory treatments and antihistamines.

The company, which already sells pharmaceuticals to a number of countries in East Africa and South East Asia, said that the move was part of its global growth strategy. Nazmul Hassan, the firm's chief executive, explained that entering the Central and South American market was a step towards gaining a foothold in "highly regulated countries."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight